
Patrick T. Lewis
Examiner (ID: 16456, Phone: (571)272-0655 , Office: P/1672 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1621, 1693, 1691, 1672, 1673 |
| Total Applications | 1936 |
| Issued Applications | 1309 |
| Pending Applications | 238 |
| Abandoned Applications | 439 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16360917
[patent_doc_number] => 20200317668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHOD OF INHIBITING OR REDUCING A CORONAVIRIDAE VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/909394
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/909394 | Method of inhibiting or reducing a viral infection | Jun 22, 2020 | Issued |
Array
(
[id] => 18604673
[patent_doc_number] => 11746123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
[patent_app_type] => utility
[patent_app_number] => 16/908416
[patent_app_country] => US
[patent_app_date] => 2020-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 144087
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1803
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16908416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/908416 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Jun 21, 2020 | Issued |
Array
(
[id] => 17790438
[patent_doc_number] => 20220249529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/620545
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620545 | Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome | Jun 18, 2020 | Issued |
Array
(
[id] => 17913222
[patent_doc_number] => 20220315617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Crosslinked Nucleoside Intermediate Crystal And Method For Producing Same, And Method For Producing Crosslinked Nucleoside Amidite
[patent_app_type] => utility
[patent_app_number] => 17/608780
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/608780 | Crosslinked nucleoside intermediate crystal and method for producing same, and method for producing crosslinked nucleoside amidite | Jun 17, 2020 | Issued |
Array
(
[id] => 17890744
[patent_doc_number] => 11453697
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-09-27
[patent_title] => Cyclic di-nucleotide compounds as sting agonists
[patent_app_type] => utility
[patent_app_number] => 16/904888
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62182
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904888 | Cyclic di-nucleotide compounds as sting agonists | Jun 17, 2020 | Issued |
Array
(
[id] => 17882719
[patent_doc_number] => 20220298196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => NOVEL COMPOUND DERIVED FROM WATERMELON, AND COMPOSITION USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/619081
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/619081 | Compound derived from watermelon, and composition using same | Jun 16, 2020 | Issued |
Array
(
[id] => 16326728
[patent_doc_number] => 20200297693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/899226
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899226 | GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF | Jun 10, 2020 | Abandoned |
Array
(
[id] => 17769367
[patent_doc_number] => 11401294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Co-crystal forms of a novobiocin analog and proline
[patent_app_type] => utility
[patent_app_number] => 16/894461
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 21115
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894461 | Co-crystal forms of a novobiocin analog and proline | Jun 4, 2020 | Issued |
Array
(
[id] => 17928343
[patent_doc_number] => 20220323468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => REDUCED NICOTINAMIDERIBOSIDES FOR THE TREATMENT/PREVENTION OF LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/595984
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595984 | REDUCED NICOTINAMIDERIBOSIDES FOR THE TREATMENT/PREVENTION OF LIVER DISEASE | Jun 2, 2020 | Pending |
Array
(
[id] => 17805789
[patent_doc_number] => 20220257624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/614055
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614055 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE | May 31, 2020 | Pending |
Array
(
[id] => 16312317
[patent_doc_number] => 20200291055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => Methods of Preparing Nicotinamide Riboside and Derivatives Thereof
[patent_app_type] => utility
[patent_app_number] => 16/886985
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886985 | Methods of preparing nicotinamide riboside and derivatives thereof | May 28, 2020 | Issued |
Array
(
[id] => 20414197
[patent_doc_number] => 12497467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Recycle content cellulose ester
[patent_app_type] => utility
[patent_app_number] => 17/595565
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 82234
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595565 | Recycle content cellulose ester | May 21, 2020 | Issued |
Array
(
[id] => 20414197
[patent_doc_number] => 12497467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Recycle content cellulose ester
[patent_app_type] => utility
[patent_app_number] => 17/595565
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 82234
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595565 | Recycle content cellulose ester | May 21, 2020 | Issued |
Array
(
[id] => 17890741
[patent_doc_number] => 11453694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Glycosyl hesperetin and process for producing the same and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/878911
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19932
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878911 | Glycosyl hesperetin and process for producing the same and uses thereof | May 19, 2020 | Issued |
Array
(
[id] => 16391005
[patent_doc_number] => 20200331946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => PROCESSES FOR THE PREPARATION OF SGLT-2 INHIBITORS, INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/876659
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876659
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/876659 | Processes for the preparation of SGLT-2 inhibitors, intermediates thereof | May 17, 2020 | Issued |
Array
(
[id] => 19870346
[patent_doc_number] => 12263184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Materials and methods for producing arabinoxylan compositions
[patent_app_type] => utility
[patent_app_number] => 17/609684
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24906
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609684 | Materials and methods for producing arabinoxylan compositions | May 7, 2020 | Issued |
Array
(
[id] => 17720578
[patent_doc_number] => 20220213298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => POROUS CELLULOSE MICROPARTICLES AND METHODS OF MANUFACTURE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/610121
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610121 | POROUS CELLULOSE MICROPARTICLES AND METHODS OF MANUFACTURE THEREOF | May 5, 2020 | Abandoned |
Array
(
[id] => 16720071
[patent_doc_number] => 20210087218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/868010
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868010 | COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS | May 5, 2020 | Abandoned |
Array
(
[id] => 16450987
[patent_doc_number] => 20200360413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Composition and Methods of Treating Acne and Photoaging
[patent_app_type] => utility
[patent_app_number] => 16/860768
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860768
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860768 | Composition and methods of treating acne and photoaging | Apr 27, 2020 | Issued |
Array
(
[id] => 16806041
[patent_doc_number] => 20210128594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/854196
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854196 | Compositions and methods for treatment of inflammatory disorders | Apr 20, 2020 | Issued |